<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001755237</identifier>
        </entity>
        <period>
            <startDate>2026-11-09</startDate>
            <endDate>2026-11-09</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001755237</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-11-09</startDate>
            <endDate>2026-11-09</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001755237</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-11-09</startDate>
            <endDate>2026-11-09</endDate>
        </period>
    </context>
    <context id="offrl_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001755237</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-11-09</startDate>
            <endDate>2026-11-09</endDate>
        </period>
    </context>
    <context id="offrl_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001755237</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-11-09</startDate>
            <endDate>2026-11-09</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-231">S-8</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-232">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-233">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-234">0001755237</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-235">Korsana Biosciences, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-238">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_2" id="ixv-239">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_3" id="ixv-240">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_4" id="ixv-241">false</ffd:PrevslyPdFlg>
    <ffd:FormTp contextRef="rc" id="ixv-293">S-8</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-294">Korsana Biosciences, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-295">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-296">Common Stock, no par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457aFlg contextRef="offrl_1" id="ixv-297">true</ffd:Rule457aFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-298"
      unitRef="Shares">5898568</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_1"
      decimals="3"
      id="ixv-299"
      unitRef="USD">30.455</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="2"
      id="ixv-300"
      unitRef="USD">179640888.44</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="6"
      id="ixv-301"
      unitRef="pure">0.000087</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="2"
      id="ixv-302"
      unitRef="USD">15628.76</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-303">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-304">Common Stock, no par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457aFlg contextRef="offrl_2" id="ixv-305">true</ffd:Rule457aFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_2"
      decimals="0"
      id="ixv-306"
      unitRef="Shares">193780</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_2"
      decimals="2"
      id="ixv-307"
      unitRef="USD">26.20</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_2"
      decimals="2"
      id="ixv-308"
      unitRef="USD">5077036.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="6"
      id="ixv-309"
      unitRef="pure">0.000087</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_2"
      decimals="2"
      id="ixv-310"
      unitRef="USD">441.70</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="offrl_3" id="ixv-311">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_3" id="ixv-312">Common Stock, no par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457aFlg contextRef="offrl_3" id="ixv-313">true</ffd:Rule457aFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_3"
      decimals="0"
      id="ixv-314"
      unitRef="Shares">550512</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_3"
      decimals="3"
      id="ixv-315"
      unitRef="USD">30.455</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_3"
      decimals="2"
      id="ixv-316"
      unitRef="USD">16765842.96</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_3"
      decimals="6"
      id="ixv-317"
      unitRef="pure">0.000087</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_3"
      decimals="2"
      id="ixv-318"
      unitRef="USD">1458.63</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="offrl_4" id="ixv-319">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_4" id="ixv-320">Common Stock, no par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457aFlg contextRef="offrl_4" id="ixv-321">true</ffd:Rule457aFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_4"
      decimals="0"
      id="ixv-322"
      unitRef="Shares">7083328</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_4"
      decimals="2"
      id="ixv-323"
      unitRef="USD">6.71</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_4"
      decimals="2"
      id="ixv-324"
      unitRef="USD">47529130.88</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_4"
      decimals="6"
      id="ixv-325"
      unitRef="pure">0.000087</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_4"
      decimals="2"
      id="ixv-326"
      unitRef="USD">4135.03</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="2" id="ixv-327" unitRef="USD">249012898.28</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="2" id="ixv-328" unitRef="USD">21664.12</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="2" id="ixv-329" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="2" id="ixv-330" unitRef="USD">21664.12</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-331">1 Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement on Form S-8 (this "Registration Statement") shall cover any additional shares of Common Stock, no par value per share (the "Common Stock"), of Korsana Biosciences, Inc. (the "Registrant") as may become issuable under the Korsana Biosciences, Inc. 2026 Stock Incentive Plan (the "2026 Plan") by reason of any stock splits, stock dividends, recapitalizations or similar transactions pursuant to the terms of the 2026 Plan. The proposed maximum aggregate offering price has been calculated pursuant to Rules 457(c) and (h) of the Securities Act based on the average of the high and low sale prices of the Common Stock, as quoted on the Nasdaq Capital Market, on November 5, 2026.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_2" id="ixv-332">2 Represents stock options outstanding under the 2026 Plan. The proposed maximum aggregate offering price has been calculated pursuant to Rule 457(h) of the Securities Act, based on the weighted-average exercise price of such outstanding options of $26.20 per share.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_3" id="ixv-333">3 Pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall cover any additional shares of Common Stock as may become issuable under the Korsana Biosciences, Inc. 2026 Employee Stock Purchase Plan (the "2026 ESPP") by reason of any stock splits, stock dividends, recapitalizations or similar transactions pursuant to the terms of the 2026 ESPP. The proposed maximum aggregate offering price has been calculated pursuant to Rules 457(c) and (h) of the Securities Act based on the average of the high and low sale prices of the Common Stock, as quoted on the Nasdaq Capital Market, on November 5, 2026.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_4" id="ixv-334">4 Pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall cover any additional shares of Common Stock as may become issuable under the assumed stock options outstanding under the Korsana Biosciences, Inc. 2025 Equity Incentive Plan (as amended, the "2025 Plan") by reason of any stock splits, stock dividends, recapitalizations or similar transactions pursuant to the terms of the 2025 Plan. The proposed maximum aggregate offering price has been calculated pursuant to Rule 457(h) of the Securities Act, based on the weighted-average exercise price of such outstanding options of $6.71 per share.</ffd:OfferingNote>
</xbrl>
